Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis
Clinical trial NCT02702180 · COMPLETED
Trial details
- NCT number
- NCT02702180
- Sponsor
- Savara Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-21
- Primary completion
- 2019-04-19
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.